Experienced in Venous Thromboembolism (VTE)

Dr. Deborah I. Friedman

Neurology | Ophthalmology
12740 Hillcrest Rd Ste 269, 
Dallas, TX 
Experienced in Venous Thromboembolism (VTE)
12740 Hillcrest Rd Ste 269, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Deborah Friedman is a Neurologist and an Ophthalmologist in Dallas, Texas. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Pseudotumor Cerebri Syndrome, Migraine, Headache, and Increased Intracranial Pressure.

Her clinical research consists of co-authoring 148 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Ophthalmology
Licenses
Ophthalmology in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

12740 Hillcrest Rd Ste 269, Dallas, TX 75230

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Preventing Depression and Anxiety: a Pilot Study of a Cystic-fibrosis Specific Cognitive-behavioral Therapy Intervention for Adolescents With CF
Preventing Depression and Anxiety: a Pilot Study of a Cystic-fibrosis Specific Cognitive-behavioral Therapy Intervention for Adolescents With CF
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Randomized, Double-Blind, Multi-Center, Parallel-Group Comparison of the Efficacy and Safety of the C213 (Zolmitriptan Microneedle System) to Placebo for the Acute Treatment of Cluster Headaches
Randomized, Double-Blind, Multi-Center, Parallel-Group Comparison of the Efficacy and Safety of the C213 (Zolmitriptan Microneedle System) to Placebo for the Acute Treatment of Cluster Headaches
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Drug
Study Drug: C213 Microneedle System
Study Phase: Phase 2/Phase 3
A Randomized, Multicenter, Double-blind, Parallel, Sham-controlled Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines. (Premium II)
A Randomized, Multicenter, Double-blind, Parallel, Sham-controlled Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines. (Premium II)
Enrollment Status: Completed
Publish Date: September 11, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Enrollment Status: Unknown
Publish Date: June 26, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

148 Total Publications

Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement.
Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement.
Journal: Headache
Published: August 14, 2025
Similar Doctors
Advanced in Venous Thromboembolism (VTE)
Dr. Steven P. Herzog
Neurology
Advanced in Venous Thromboembolism (VTE)
Dr. Steven P. Herzog
Neurology

Texas Neurology, P.A.

6080 N Central Expy, Ste 100, 
Dallas, TX 
 (5.8 miles away)
972-449-0540
Experience:
40+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Herzog is a Neurologist in Dallas, Texas. Dr. Herzog has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Migraine, Migraine with Brainstem Aura, Chronic Pain, and Vertebral Artery Dissection.

Experienced in Venous Thromboembolism (VTE)
Dr. Wei Y. Tang
Neurology
Experienced in Venous Thromboembolism (VTE)
Dr. Wei Y. Tang
Neurology

Healthtexas Provider Network

821 N Coleman St, Suite 100, 
Prosper, TX 
 (22.2 miles away)
469-800-5200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wei Tang is a Neurologist in Prosper, Texas. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Memory Loss, Movement Disorders, Parkinson's Disease, and Epilepsy. Dr. Tang is currently accepting new patients.

Experienced in Venous Thromboembolism (VTE)
Dr. Justin F. Rousseau
Neurology | Public Health and Preventive Medicine
Experienced in Venous Thromboembolism (VTE)
Dr. Justin F. Rousseau
Neurology | Public Health and Preventive Medicine

University Of Texas Southwestern Medical Center At Dallas

5200 Harry Hines Blvd, 
Dallas, TX 
 (8.2 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Justin Rousseau is a Neurologist and a Public Health and Preventive Medicine provider in Dallas, Texas. Dr. Rousseau is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Delirium, Seizures, Encephalitis, and Rasmussen Encephalitis. Dr. Rousseau is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Friedman's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile